To enable progress towards parity, it will be critical that open data sharing standards be adopted for all ancestries and for genetic studies of all sample sizes, not just the largest European results. Locally appropriate and secure genetic data sharing techniques as well as equitable technology availability will need to be adopted widely in Asia and Africa as they are in Europe and North America, to ensure that maximum value is achieved from existing and ongoing efforts that are being developed to help counter the current imbalance. Simultaneously, ethical considerations require that research capacity is increased in LMICs with simultaneous growth of diverse population studies to balance the benefits of these studies to scientists and patients globally versus locally to ensure that everyone benefits. Methodological improvements that better define risk scores by accounting for population allele frequency, LD, and/or admixture differences appropriately are underway and may help considerably but will not by themselves bring equality. All of these efforts are important and should be prioritized not just for risk prediction but more generally to maximize the use and applicability of
